Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lyra Therapeutics (LYRA) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Lyra Therapeutics (LYRA) over the last 3 years, with Q3 2025 value amounting to $3000.0.

  • Lyra Therapeutics' Tax Provisions fell 5714.29% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15000.0, marking a year-over-year decrease of 7000.0%. This contributed to the annual value of $39000.0 for FY2024, which is 3389.83% down from last year.
  • According to the latest figures from Q3 2025, Lyra Therapeutics' Tax Provisions is $3000.0, which was down 5714.29% from $2000.0 recorded in Q2 2025.
  • In the past 5 years, Lyra Therapeutics' Tax Provisions registered a high of $17000.0 during Q4 2023, and its lowest value of $2000.0 during Q2 2025.
  • Over the past 3 years, Lyra Therapeutics' median Tax Provisions value was $12000.0 (recorded in 2023), while the average stood at $9727.3.
  • Per our database at Business Quant, Lyra Therapeutics' Tax Provisions changed by 0.0% in 2024 and then plummeted by 8333.33% in 2025.
  • Quarter analysis of 3 years shows Lyra Therapeutics' Tax Provisions stood at $17000.0 in 2023, then plummeted by 64.71% to $6000.0 in 2024, then tumbled by 50.0% to $3000.0 in 2025.
  • Its last three reported values are $3000.0 in Q3 2025, $2000.0 for Q2 2025, and $4000.0 during Q1 2025.